Navigation Links
BD Board of Directors Elects Cathy E. Minehan
Date:11/2/2007

FRANKLIN LAKES, N.J., Nov. 2 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it has elected Cathy E. Minehan to its Board of Directors, effective November 19, 2007.

Ms. Minehan, 60, most recently served as President and Chief Executive Officer of the Federal Reserve Bank of Boston, one of 12 regional Reserve Banks that together with the Board of Governors in Washington, D.C. form the Federal Reserve System. She held this position from 1994 until her retirement in July 2007. Ms. Minehan also served as a member of the Federal Open Market Committee, the body responsible for U.S. monetary policy.

"We are honored to welcome Cathy Minehan, who had a distinguished tenure as one of the nation's central bankers, to the BD Board," said Edward J. Ludwig, BD Chairman, President and Chief Executive Officer. "Cathy offers the Board expertise in financial and economic policymaking gained over a notable career of nearly 40 years with the Federal Reserve. This acumen, coupled with her civic and business leadership experience, will bring a wealth of valuable skills and perspective to the Board."

Ms. Minehan joined the Federal Reserve in 1968 as a bank examiner at the Federal Reserve Bank of New York. Rising through the ranks, she served in a variety of roles in Public Information and Accounting Control as well as Check Processing, Accounting, Funds and Securities. In 1991, she was appointed First Vice President and Chief Operating Officer of the Federal Reserve Bank of Boston, a position she held until 1994 when she was appointed President and Chief Executive Officer.

Ms. Minehan serves on the boards of Visa, Inc. and many civic, professional and educational organizations, including Massachusetts General Hospital, the Partners Health Care System, the University of Rochester and the Boston Private Industry Council. She is an Investment Advisory Board Member of Massachusetts Institute of Technology as well as a member and former Chair of The United Way of Massachusetts Bay Board of Directors. Ms. Minehan holds an M.B.A. with distinction from New York University, where she earned the Business Forum Prize for Excellence in Economics in 1977. She obtained her undergraduate degree from the University of Rochester.

With her election, the BD board will consist of 14 members, all of whom are independent with the exception of Mr. Ludwig.

About BD

BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people's health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs more than 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit http://www.bd.com.

Contacts:

Colleen T. White, Corporate Communications - 201-847-5369

Patricia A. Spinella, Investor Relations - 201-847-5453


'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Study casts doubt on keyboard ills
2. Who Board To Discuss Asian Tsunami Related Health Issues
3. Abdominal Crunches Not The Best Option For Wash Board Abs.
4. Computer Keyboards In Hospitals Could Spread Infection To Patients
5. Flu, Boarded A Ship?
6. Skateboarding to health
7. Shangai Citizens to Monitor Billboards
8. Budhia Is Fine, Government-constituted Medical Board Reports False
9. Pharmacy Board Says Pharmacists Have Right To Refuse Morning-After Pill
10. 115 people on board a cruise liner taken ill due to suspected Norovirus
11. Health Board and Doctors’ Association clash on working hours issu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
Breaking Medicine Technology: